Heather Bresch, the Mylan CEO under fire for skyrocketing EpiPen costs, believes Americans should redirect their anger toward a "broken" health care system.
Mylan (
MYL) was forced to respond to the national outrage over a
more than 400% increase in price for the lifesaving allergy treatment by
pledging on Thursday to make it more affordable.
But Bresch argued that a lack of transparency in the complex health care system -- with bigger cuts for everyone from the pharmacy to the wholesaler -- "incentivizes higher prices" in the industry. She pointed out that copays and deductibles are on the rise, too.
"This system needs to be fixed. No one knows what anything costs," Bresch
told CNBC on Thursday.
The Mylan CEO compared the health care industry to the real estate mortgage crisis of 2008.
"Our health care system is in a crisis...This bubble is going to burst," Bresch said.
"Hey, but look at everything else?" is her response? Um, the profiteering is the problem. Not coincidentally, the CEO salary has increased 600% in the same timeframe.